Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Short-term management of insomnia Age: Adult |
Dose: Oral – 7.5 mg Frequency: at bedtime |
|
Indication: Short-term management of insomnia Age: Elderly |
Dose: Oral – 3.75 mg Frequency: at bedtime Note: Initially |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: No approved pediatric dosage available Note: Not recommended |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Tablet – 3.75 mg Frequency: at bedtime Note: Initiate at 3.75 mg at bedtime for renal impairment. |
Administration
- Can be taken with or without food
- Take just before bedtime
Side Effect
- Metallic or bitter aftertaste
- irritability
- confusion
- depressed mood
- aggressiveness
- incoordination
- anterograde amnesia
- mild increase in LFTs
- drowsiness
- lightheadedness
- nausea
- vomiting
- urticaria
- rashes
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Phenytoin, carbamazepine
|
Reduced hypnotic effect
|
|
TCAs
|
Increased drowsiness and incoordination
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Myasthenia Gravis
|
Can worsen muscle weakness
|
|
Respiratory Failure
|
Risk of respiratory depression
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a dry place, at room temperature (15°C to 30°C). Protect from light. Keep in a safe place out of reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.